Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 TELEO Capital Acquires Applied Materials’ Pharmaceutical Manufacturing Intelligence Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

TELEO Capital Acquires Applied Materials’ Pharmaceutical Manufacturing Intelligence Platform

Investment in Modersys will be focused on the life sciences sectors to support faster product investment decisions and longer-term customer partnerships.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

TELEO Capital Management, LLC has acquired SmartFactory Rx (“SmartFactory” or “Modersys”), a leading pharmaceutical manufacturing intelligence platform, from Applied Materials, Inc. SmartFactory has been rebranded as Modersys as part of the transaction.

Modersys is designed to help biopharmaceutical, nutritional, and other life sciences companies improve yield, reduce variability, accelerate time to market, and maintain regulatory fidelity. Its platform combines real-time analytics, AI/ML process intelligence, advanced process control, adaptive scheduling, and alarm management across the full manufacturing lifecycle – from early-stage process development through GMP commercial production. Modersys operational platform has been deployed across the U.S., Europe, and Asia Pacific for the world’s most demanding manufacturing environments.

Across customer deployments, the platform has delivered measurable results, including yield improvements of up to 10%, throughput gains of up to 15%, reductions in experimental effort of up to 50%, and equipment availability gains of more than 22 days per plant per year, according to the company.

“Modersys represents exactly the kind of mission-critical, deeply differentiated software platform that we were built to acquire,” said TELEO Capital. As an independent company, Modersys will have the focus, investment, and agility to accelerate product innovation to meet customer demands globally.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics